Study Stopped
The participating centers were not opened on time, and the inclusion period has expired. A Substantial amendment is in progress to extend the inclusion period.
Pilot Study on the Feasibility of Systematic Hepatitis C Screening of Hospitalized Patients
HOSPI-VHC
Pilot Study of the Feasibility of Routine Inpatient Hepatitis C Screening
2 other identifiers
interventional
2,500
1 country
4
Brief Summary
The Ministry of Health has set the target of eradicating hepatitis C (HCV) in France by 2025. The goal is to validate the feasibility and value of conducting routine HCV screening in hospitalized patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2020
Longer than P75 for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 22, 2020
CompletedFirst Posted
Study publicly available on registry
May 28, 2020
CompletedStudy Start
First participant enrolled
September 21, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 21, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 21, 2026
ExpectedJuly 3, 2025
June 1, 2025
3.8 years
May 22, 2020
June 30, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
potential patient versus
Number of HCV serologies collected compared to the number of patients meeting the inclusion criteria during the study period.
7 days
Secondary Outcomes (6)
HCV positive
7 days
Follow-up
2 months
Polymerase chain reaction (PCR)
7 days
Viral risk factor
7 days
hepatic fibrosis
7 days
- +1 more secondary outcomes
Study Arms (1)
Hepatitis C testing
OTHERIf the patient is included in the study, HCV serology (2 x 5 ml tubes) will be taken at the time of admission as part of the routine entry assessment. These two tubes will be used for HCV screening. The patient is informed of the HCV serology result during hospitalization by an investigator.
Interventions
Eligibility Criteria
You may qualify if:
- Patient over 18 years of age
- Hospitalized during the study period
- Non-opposition for participation in the Protocol
You may not qualify if:
- Patients under 18 years of age
- Outpatient, long-stay, maternity and intensive care inpatients
- Patients refusing blood collection
- Patient may not understand the information sheet
- Patient under guardianship
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
CHI Créteil
Créteil, 94000, France
Grand Hôpital de l'Est Francilien - Site de Marne-la-Vallée
Jossigny, France
CH Meaux
Meaux, France
CHIV
Villeneuve-Saint-Georges, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 22, 2020
First Posted
May 28, 2020
Study Start
September 21, 2020
Primary Completion
June 21, 2024
Study Completion (Estimated)
June 21, 2026
Last Updated
July 3, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share